Literature DB >> 33605059

Serum macrophage inhibitory cytokine-1 as a clinical marker for non-small cell lung cancer.

Chunhua Xu1,2, Li Li1,2, Wei Wang1,2, Qian Zhang1,2, Xiuwei Zhang3, Rusong Yang4.   

Abstract

The aim of this study was to investigate the value of serum macrophage inhibitory factor-1 (MIC-1) level in patients with non-small cell lung cancer (NSCLC). Serum samples from 296 patients with NSCLC and 240 healthy controls were collected. The levels of serum MIC-1 were determined by ELISA. The serum MIC-1 levels in NSCLC patients were higher than that of the controls (P <.001). Univariate and multivariate Cox regression analysis showed that serum MIC-1 was an independent prognostic indicator of OS and PFS. Serum MIC-1 is a valuable biomarker for the diagnosis and prognosis of NSCLC.
© 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  diagnosis; macrophage inhibitory cytokine-1; non-small cell lung cancer; prognosis

Year:  2021        PMID： 33605059      PMCID： PMC7957168          DOI： 10.1111/jcmm.16360

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN： 1582-1838            Impact factor:   5.310


  13 in total

1.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

2.  Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality.

Authors:  Raaj S Mehta; Dawn Q Chong; Mingyang Song; Jeffrey A Meyerhardt; Kimmie Ng; Reiko Nishihara; Zhirong Qian; Teppei Morikawa; Kana Wu; Edward L Giovannucci; Charles S Fuchs; Shuji Ogino; Andrew T Chan
Journal:  Gastroenterology       Date:  2015-05-27       Impact factor: 22.682

3.  Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer.

Authors:  Kyoko Okamura; Koichi Takayama; Miiru Izumi; Taishi Harada; Kazuto Furuyama; Yoichi Nakanishi
Journal:  Lung Cancer       Date:  2013-01-23       Impact factor: 5.705

4.  Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.

Authors:  Chun-Hua Xu; Zhi-Hong Sheng; Hui-Di Hu; Ke-Ke Hao; Qing-Bo Wang; Li-Ke Yu
Journal:  Tumour Biol       Date:  2014-05-29

5.  Diet-induced macrophage inhibitory cytokine 1 promotes prostate cancer progression.

Authors:  Mingguo Huang; Shintaro Narita; Takamitsu Inoue; Norihiko Tsuchiya; Shigeru Satoh; Hiroshi Nanjo; Takehiko Sasaki; Tomonori Habuchi
Journal:  Endocr Relat Cancer       Date:  2013-12-16       Impact factor: 5.678

6.  Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancer.

Authors:  Ji Li; Robert W Veltri; Zhen Yuan; Christhunesa S Christudass; Wlodek Mandecki
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

7.  Serum macrophage inhibitory cytokine-1 as a clinical marker for non-small cell lung cancer.

Authors:  Chunhua Xu; Li Li; Wei Wang; Qian Zhang; Xiuwei Zhang; Rusong Yang
Journal:  J Cell Mol Med       Date:  2021-02-18       Impact factor: 5.310

8.  Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1.

Authors:  M Mimeault; S L Johansson; S K Batra
Journal:  Br J Cancer       Date:  2013-02-28       Impact factor: 7.640

9.  Macrophage Inhibitory Cytokine-1 as a Novel Diagnostic and Prognostic Biomarker in Stage I and II Nonsmall Cell Lung Cancer.

Authors:  Yu-Ning Liu; Xiao-Bing Wang; Teng Wang; Chao Zhang; Kun-Peng Zhang; Xiu-Yi Zhi; Wei Zhang; Ke-Lin Sun
Journal:  Chin Med J (Engl)       Date:  2016-09-05       Impact factor: 2.628

10.  [Macrophage Inhibitory Cytokine-1 (MIC-1) as A Biomarker for Diagnosis 
and Prognosis of Stage I-II Non-small Cell Lung Cancer].

Authors:  Yuning Liu; Xiaobing Wang; Teng Wang; Chao Zhang; Kunpeng Zhang; Ruochuan Zang; Xiuyi Zhi; Wei Zhang; Kelin Sun
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-04-20
View more
  1 in total

1.  Serum macrophage inhibitory cytokine-1 as a clinical marker for non-small cell lung cancer.

Authors:  Chunhua Xu; Li Li; Wei Wang; Qian Zhang; Xiuwei Zhang; Rusong Yang
Journal:  J Cell Mol Med       Date:  2021-02-18       Impact factor: 5.310
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.